Littlejohn & Co. LLC Invests $1.85 Million in Aveanna Healthcare Holdings Inc. $AVAH

Littlejohn & Co. LLC acquired a new position in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 215,505 shares of the company’s stock, valued at approximately $1,846,878. Aveanna Healthcare comprises about 0.0% of Littlejohn & Co. LLC’s holdings, making the stock its 8th biggest holding. Littlejohn & Co. LLC owned about 0.10% of Aveanna Healthcare at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of AVAH. Caitong International Asset Management Co. Ltd lifted its holdings in shares of Aveanna Healthcare by 252.4% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock valued at $27,000 after purchasing an additional 2,400 shares during the last quarter. Quantbot Technologies LP acquired a new position in Aveanna Healthcare in the second quarter valued at approximately $43,000. Summit Securities Group LLC bought a new stake in shares of Aveanna Healthcare in the 1st quarter worth approximately $53,000. Oxford Asset Management LLP purchased a new stake in Aveanna Healthcare in the second quarter worth approximately $64,000. Finally, C M Bidwell & Associates Ltd. purchased a new position in shares of Aveanna Healthcare during the second quarter valued at approximately $69,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have weighed in on AVAH shares. Raymond James Financial boosted their target price on shares of Aveanna Healthcare from $13.00 to $15.00 and gave the stock a “strong-buy” rating in a research report on Friday, August 14th. Royal Bank Of Canada increased their price target on Aveanna Healthcare from $10.00 to $16.00 and gave the company an “outperform” rating in a research note on Monday. Truist Financial increased their target price on Aveanna Healthcare from $11.00 to $15.00 and gave the stock a “hold” rating in a report on Monday. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Aveanna Healthcare in a research report on Thursday, July 2nd. Finally, UBS Group raised their price objective on shares of Aveanna Healthcare from $8.00 to $13.00 and gave the company a “neutral” rating in a research note on Friday, August 14th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Aveanna Healthcare has an average rating of “Moderate Buy” and an average target price of $13.50.

Insider Transactions at Aveanna Healthcare

In related news, CEO Jeff Shaner sold 90,000 shares of Aveanna Healthcare stock in a transaction dated Thursday, August 20th. The stock was sold at an average price of $11.50, for a total value of $1,035,000.00. Following the completion of the transaction, the chief executive officer owned 2,561,972 shares in the company, valued at $29,462,678. The trade was a 3.39% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, major shareholder J.H. Whitney Equity Partners V sold 2,250,000 shares of Aveanna Healthcare stock in a transaction on Friday, August 21st. The stock was sold at an average price of $11.50, for a total transaction of $25,875,000.00. Following the sale, the insider owned 12,315,892 shares in the company, valued at $141,632,758. This represents a 15.45% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 79,746,745 shares of company stock valued at $773,117,091. Company insiders own 5.30% of the company’s stock.

Aveanna Healthcare Price Performance

Aveanna Healthcare stock traded down $0.50 during midday trading on Friday, reaching $13.32. The company’s stock had a trading volume of 2,220,926 shares, compared to its average volume of 1,829,213. The firm has a market capitalization of $2.91 billion, a PE ratio of 10.83, a P/E/G ratio of 0.86 and a beta of 1.90. The company has a debt-to-equity ratio of 4.47, a quick ratio of 1.16 and a current ratio of 1.16. The stock’s 50 day simple moving average is $10.07 and its 200 day simple moving average is $8.08. Aveanna Healthcare Holdings Inc. has a fifty-two week low of $5.93 and a fifty-two week high of $14.00.

Aveanna Healthcare (NASDAQ:AVAH) last issued its earnings results on Thursday, August 13th. The company reported $0.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.17 by $0.05. The business had revenue of $670.48 million for the quarter, compared to analysts’ expectations of $638.61 million. Aveanna Healthcare had a return on equity of 80.70% and a net margin of 10.56%. On average, equities research analysts forecast that Aveanna Healthcare Holdings Inc. will post 0.75 earnings per share for the current year.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.